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Background:  The purpose of this study was to characterize right atrial (RA) and ventricular (RV) molecular changes in chronic pulmonary 
hypertension (CPH) using two models: monocrotaline (DMCT) toxicity and pulmonary artery (PA) banding.
Methods:  18 dogs underwent sternotomy and: 1.) DMCT toxicity (36% rise in RVP at 10 weeks, n=5), 2.) Moderate PA banding to match the RVP 
rise with DMCT (n=5), 3.) PA banding to generate severe CPH (2.5 fold RVP increase, n=4), and 4.) control (n=4). At 10 weeks, RA and RV tissue were 
examined using immunoblotting for sarcoplasmic reticulum Ca2+-ATPase (SERCA), phospholamban (PLB), and serine-16 phosphorylated PLB.
Results:  Right Ventricle: With DMCT, there was no change in SERCA (p=0.50) or PLB (p=0.42), but a trend to downregulation of ser 16 pPLB 
(p=0.07) (see Table). Similarly, with moderate PA banding, there was no change in SERCA (p=0.25) or PLB (p=0.33), but ser 16 pPLB was 
downregulated (p<0.001). With severe PA banding, there was no change in PLB (p=0.33), but SERCA and ser 16 pPLB fell (p<0.001). Right Atrium: 
With DMCT, there were no changes (p>0.12). With moderate and severe PA banding, ser 16 pPLB fell (p=0.02), but SERCA (p=0.57) and PLB 
(p=0.29) did not change.
Conclusions:  In the RV, SERCA fell only with severe CPH, but ser 16 pPLB was downregulated at all levels of CPH. In the RA, molecular changes 
were blunted, but ser 16 pPLB fell with PA banding. Thus, in CPH, molecular changes depend on the degree of RV overload and are similar, but 
blunted, in the RA compared to the RV.
*p<0.05 vs. Control (ANOVA, Fisher’’s PLSD)
Control DMCT
Moderate
PA band
Severe
PA band
Right Ventricle
SERCA 1.00±0.18 1.04±0.09 0.78±0.30 0.43±0.18*
PLB 1.00±0.10 1.19±0.41 0.82±0.19 0.84±0.28
ser 16 pPLB 1.00±0.16 0.74±0.19 0.26±0.30* 0.33±0.20*
Right Atrium
SERCA 1.00±0.14 1.12±0.09 1.07±0.23 0.88±0.33
PLB 1.00±0.18 1.00±0.07 0.97±0.24 0.72±0.10
ser 16 pPLB 1.00±0.23 0.88±0.44 0.40±0.39* 0.37±0.34*
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